Exploring Growth Opportunities and Trends in the US companion diagnostics (CDx) development market
Market Overview
The U.S. companion diagnostics (CDx) development market was valued at USD 412.84 million in 2024 and is anticipated to register a CAGR of 7.8% from 2025 to 2034.
The U.S. is a global leader in CDx development due to advanced healthcare infrastructure, a strong biopharmaceutical ecosystem, and supportive regulatory frameworks. Rising investments in oncology research,...
0 Comments
0 Shares